Research Article
Efficacy and Safety of Kleeb Bua Daeng Formula in Mild Cognitive Impairment Patients: A Phase I Randomized, Double-Blind, Placebo-Controlled Trial
Table 5
Mean difference level of serum AST and ALT between KBD and placebo groups.
| | Study month | Mean difference of AST (95% confidence interval) | value | Mean difference of ALT (95% confidence interval) | value |
| | Month 1 | 0.75 (−2.66, 4.16) | 0.666 | −1.70 (−7.55, 4.15) | 0.569 | | Month 2 | 1.15 (−2.33, 4.63) | 0.517 | −1.79 (−7.77, 4.18) | 0.556 | | Month 3 | 0.03 (−3.48, 3.54) | 0.985 | −4.81 (−10.84, 1.21) | 0.117 |
|
|
The multilevel mixed-effect linear regression model was used in analyzing mean difference.
|
